Intellipharmaceutics International Inc. (IPCI)

[fabius]

Sure this decision (CIGNA's) could be a big catalyst, more so if other insurer do follow (which is likely to me).

This should put some pressure for the first time to Purdue; delay tactics are becoming no more the best route for them !!
If IPCI is not a bunch of romantic scientists (which still has to be proven for us shareholders) I see a partnership as a win-win, I would say a natural outcome.

I remember one year ago when writing with Samsa I more than once indicated as IPCI should have partnered with Purdue, BEFORE AdComm.

Also likely a total different story going for a Rexista final approval with Purdue already partnered...(someone as wheezul would receive a special courtesy visit before appearing in front of any possible AdComm).
by the way...is there going to be another AdComm once the reviewed NDA will be submitted under the new FDA requirements?

And my last point: COLL has a mkt cap of 330Mln, revenue as of 30th june 2017 of 7.4mln, EPS -3.66.